SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-KSB
(Mark One)

[ X ] ANNUAL  REPORT  PURSUANT  TO  SECTION  13 OR  15(d)  OF THE  SECURITIES
      EXCHANGE ACT OF 1934

                   For the fiscal year ended December 31, 2005

                                       OR

[    ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934

          From the transition period from ____________ to ___________.

                         Commission File Number 0-33107

                               MED-X SYSTEMS, INC.
        -----------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)

         Nevada                                            76-0238783
--------------------------------               ---------------------------------
(State or other jurisdiction of                (IRS Employer Identification No.)
 incorporation or organization)


                      1301 Travis, #1200, Houston, TX 77002
                    ------------------------------------------
                    (Address of principal executive offices)

                                 (713) 547-8900
                           ----------------------------
                           (Issuer's telephone number)

       Class                   Shares Outstanding                  Date
       -----                   ------------------                  ----
Common, no par value                 596,469                 December 31, 2006

         Indicate by check mark whether the registrant (1) filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days:
                                   Yes No |X|

         Check if there is no disclosure of delinquent filers in response to
Item 405 of Regulation S-B contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this form10-KSB
or any amendment to this Form 10-KSB. |_|

         Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act)

                                 Yes |X| No |_|

         The Issuer's revenues for the fiscal year ended December 31, 2005 were
$0.

         The aggregate market value of the voting and non-voting equity held by
non-affiliates computed by reference to the price at which the common equity was
sold is $0.


                       DOCUMENTS INCORPORATED BY REFERENCE

None
         Transition Small Business Disclosure Format:   Yes  [  ]   No  [ X ]


<PAGE>

                               MED-X SYSTEMS, INC.
                                      INDEX

                                TABLE OF CONTENTS

                                                                         Page

PART I

         ITEM 1.   DESCRIPTION OF BUSINESS...............................  1
         ITEM 2.   DESCRIPTION OF PROPERTY...............................  1
         ITEM 3.   LEGAL PROCEEDINGS.....................................  1
         ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF
                   SECURITY HOLDERS......................................  1

PART II

         ITEM 5.   MARKET FOR COMMON EQUITY
                   RELATED STOCKHOLDER MATTERS AND SMALL BUSINESS ISSUER
                   PURCHASER OF EQUITY SECURITIES........................  1
         ITEM 6.   MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN
                   OF OPERATION..........................................  2
         ITEM 7.   FINANCIAL STATEMENTS..................................  4
         ITEM 8.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
                   ON ACCOUNTING AND FINANCIAL DISCLOSURE................ 10
         ITEM 8A.  CONTROLS AND PROCEDURES............................... 10
         ITEM 8B.  OTHER INFORMATION.....................................

PART III

         ITEM 9.   DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND
                   CONTROL PERSONS AND CORPORATE GOVERNANCE
                   COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT..... 10
         ITEM 10.  EXECUTIVE COMPENSATION................................ 10
         ITEM 11.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
                   OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER
                   MATTERS............................................... 11
         ITEM 12.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS........ 11
         ITEM 13.  EXHIBITS.............................................. 11
         ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES................ 11


SIGNATURES         ...................................................... 11




<PAGE>


                                     PART I

ITEM 1.   DESCRIPTION OF   BUSINESS

History and Development of the Company

Med-X Systems, Inc. ("Med-X") was incorporated in the State of Texas on December
21, 1987 to engage in the business of the management and processing of insurance
claims for the medical profession. Unicorp, Inc. acquired 100% of the
outstanding capital stock of Med-X on July 31, 1988. The Company ceased active
business operations and liquidated its operating assets in 1989. No material
business operations have been conducted since that time. Since 1992, Med-X's
activities have consisted primarily of maintaining its corporate status through
filing franchise tax returns and paying franchise taxes. Med-X currently has no
assets.

On August 17, 2001 to facilitate a spin-off of Med-X Systems, Inc. to its
shareholders, Unicorp, Inc. the parent of Med-X Systems, Inc. caused Med-X
Systems, Inc. to file a registration statement with United States Securities &
Exchange Commission. This registration became effective on October 16, 2001.
However, the spin-off of Med-X Systems, Inc. although approved in 2001, was not
completed until the close of business on September 30, 2004. Under the terms of
the spin-off, each shareholder of Unicorp, Inc. received, or is entitled to
receive, one share of Med-X Systems, Inc. common stock for each share of common
stock held of Unicorp, Inc.

On May 2, 2002, Med-X redomiciled to Nevada.

Med-X is currently seeking to identify and complete a merger or acquisition with
a private entity and commence business operations.

ITEM 2.  DESCRIPTION OF PROPERTY

Med-X does not currently own or operate any physical plants or other property.
Med-X is provided administrative office space, at no cost, at 1301 Travis, Suite
1200, Houston, Texas 77002.

ITEM 3. LEGAL PROCEEDINGS

We are not a party to any pending litigation and were not aware of any
threatened litigation.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted, during the fourth quarter of the fiscal year covered
by this report, to a vote of security holders, through the solicitation of
proxies or otherwise.


                                     PART II

ITEM 5. MARKET FOR REGISTRANT'S  COMMON EQUITY,  RELATED STOCKHOLDER MATTERS AND
        SMALL BUSINESS ISSUES PURCHASE OF EQUITY SECURITIES

At present, there is no trading market for Med-X's common stock.

There are approximately 970 holders of record of Med-X common stock as of
December 31, 2005 and 2004.

Med-X has not declared any dividend on common equity and does not intend to do
so in the foreseeable future.

Med-X has not sold securities within the past three fiscal years.


                                       1
<PAGE>


ITEM 6. MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

CRITICAL ACCOUNTING POLICIES

The process of preparing financial statements requires the use of estimates on
the part of management. Management's discussion and analysis of results of
operations and financial condition are based upon the Company's financial
statements. These statements have been prepared in accordance with accounting
principles generally accepted in the United States of America. These principles
require management to make certain estimates, judgments and assumptions that
affect the reported amounts of assets, liabilities, revenues and expenses, and
related disclosure of contingent assets and liabilities. On an on-going basis,
we evaluate our estimates, based on historical experience, and various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources.
Actual results may differ from these estimates under different assumptions or
conditions.


PLAN OF OPERATION

During the years ended December 31, 2005 and 2004, the Company had no operations
other than the search for a business to acquire or with which to combine.


The Company reported no revenues for either of the years ended December 31, 2005
or 2004. The Company incurred $10,000 of expenses during the years ended
December 31, 2005and 2004 respectively. All of these expenses were incurred for
state and SEC filings.


MATERIAL CHANGES IN FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

At December 31, 2005 the Company had no current assets and $37,500 of current
liabilities as compared to no current assets and $27,500 of current liabilities
at December 31, 2004.

All of the services for the Company's filings are provided by the Company's
president who also pays all of the Company's filing fees and audit expenses.
Unless these services and expense advances continue, the company will have
insufficient capital to pay for its statutory filings or continue operations,
However, although the Company has no liquidity, it believes that it will be able
to find a suitable Company to acquire or with which to combine.


OFF-BALANCE SHEET ARRANGEMENTS


We have not participated nor were we a party to any agreement to participate in
any off-balance sheet arrangements.


                                       2
<PAGE>

             Report of Independent Registered Public Accounting Firm


The Board of Directors and Stockholders
Med-X Systems, Inc.

We have audited the accompanying balance sheets of Med-X Systems, Inc. (the
"Company") (a corporation in the development stage), as of December 31, 2005 and
2004, and the related statements of operations, stockholders' deficit and cash
flows for the two years then ended and the period from January 1, 1999
(inception) to December 31, 2005. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audit. The financial
statements for the period from January 1, 1999 (inception) to December 31, 2001
were audited by other auditors whose report expressed an unqualified opinion on
those statements. The financial statements for the period from January 1, 1999
(inception) to December 31, 2001, reflect no revenues and a net loss of $1,000
of the related totals. Our opinion insofar as it relates to the amounts included
for such a prior period, is based solely on the report of other such auditors.

We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.

In our opinion, based on our audit and the report of other auditors, the
financial statements referred to above present fairly, in all material respects,
the financial position of Med-X Systems, Inc. as of December 31, 2005 and 2004,
and the results of its operations, and its cash flows for the two years then
ended and the period from January 1, 1999 (inception) to December 31, 2005 in
conformity with accounting principles generally accepted in the United States of
America.

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 2 to the
financial statements, the Company does not have assets or sources of revenue,
which raises substantial doubt about its ability to continue as a going concern.
Management's plans regarding those matters also are described in Note 2. The
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.

Thomas Leger & Co. L.L.P.
January 2, 2007
Houston, Texas


                                       3
<PAGE>


ITEM 7.  FINANCIAL STATEMENTS


                               MED-X SYSTEMS, INC.
                          (A Development Stage Company)
                                 Balance Sheets


                                    Assets

                                                    December 31,    December 31,
                                                       2005              2004

Current Assets

      Cash                                       $            0      $        0
                                                   -------------       --------
      Total Current Assets                                    0               0
                                                   -------------       --------
Total Assets                                     $            0      $        0
                                                   =============       ========

           Liabilities & Stockholders' Deficit
Current Liabilities

      Accounts Payable - Director                $        37,500     $   27,500
                                                    -------------      ---------
Total Current Liabilities                                 37,500         27,500
                                                    -------------      ---------
Stockholders' Deficit
      Preferred stock; no par 50,000,000
      shares authorized, none issued
      Common stock; no par 200,000,000 shares
      authorized 596,469 issued                                -              -
      and outstanding                                      1,000          1,000

Additional paid-in Capital                                     -              -

Deficit accumulated during development stage             (38,500)       (28,500)
                                                    -------------      ---------
Total Stockholders' Deficit                              (37,500)       (27,500)
                                                    -------------      ---------
Total Liabilities & Stockholders' Deficit        $            0      $        0
                                                    =============      =========

              The accompanying notes are an integral part of these
                             financial statements.


                                       4
<PAGE>

                             MED-X SYSTEMS USA, INC.
                          (A Development Stage Company)
                            Statements of Operations

                                                                From Inception
                               For the Year Ended December    (January 1, 1999)
                                           31,              Through December 31,
                                  2005            2004              2005

REVENUES                       $        0    $          0     $               0
                               -----------    ------------     -----------------
EXPENSES
     Administrative
     Expenses                      10,000          10,000                38,500
                               -----------    ------------     -----------------

       Total Expenses              10,000          10,000                38,500
                               -----------    ------------     -----------------
NET LOSS                       $  (10,000)    $   (10,000)     $        (38,500)
                               ===========    ============     -----------------

(LOSS) PER SHARE               $    (0.02)    $     (0.02)
                               ===========    ============
WEIGHTED AVERAGE SHARES
OUTSTANDING                       596,469          596,469
                               ===========    ============

              The accompanying notes are an integral part of these
                             financial statements.


                                       5
<PAGE>

                               MED-X SYSTEMS, INC.
                          (A Development Stage Company)
                       Statements of Stockholders' Deficit

                 For the Years ended December 31, 2005 and 2004,
                  and for the period from Inception (January 1,
                           1999) to December 31, 2005


<TABLE>

                                                                   Losses
                                                                accumulated
                                          Common      Stock      during the
                                          Shares      Amount   Development Stage     Total
                                        ----------   --------  ------------------   --------
<S>                                     <C>           <C>      <C>                  <C>


Balance at inception, January 1,              0          $0             $0                $0
1999

Organizational services performed
by the Parent considered effective
January 1, 1999                         596,469       1,000              -             1,000

Net loss                                      -           -              -                 -
                                        --------     -------        --------         ---------
Balance at December 31, 1999            596,469       1,000         (1,000)                -

Net loss                                      -           -              -                 -
                                        --------     -------        --------         ---------
Balance at December 31, 2000            596,469       1,000         (1,000)                -

Net loss                                      -           -              -                 -
                                        --------     -------        --------         ---------

Balance December 31, 2001               596,469       1,000         (1,000)                -

Net loss                                      -           -         (7,500)           (7,500)
                                        --------     -------        --------         ---------
Balance at December 31, 2002            596,469       1,000         (8,500)           (7,500)

Net loss                                      -           -        (10,000)          (10,000)
                                        --------     -------        --------         ---------
Balance at December 31, 2003             596,469      $1,000       ($18,500)         ($17,500)

Net loss                                       -           -        (10,000)          (10,000)
                                        --------     -------        --------         --------

Balance at December 31, 2004             596,469      $1,000       ($28,500)         ($27,500)

Net loss                                       -           -        (10,000)           10,000
                                        --------     -------        --------         --------
Balance at December 31, 2005             596,469      $1,000       ($38,500)         ($37,500)


</TABLE>

              The accompanying notes are an integral part of these
                             financial statements.

                                       6
<PAGE>


                               MED-X SYSTEMS, INC.
                          (A Development Stage Company)
                            Statements of Cash Flows
<TABLE>


                                                 For the Year Ended          From Inception
                                                    December 31,            (January 1, 1999)
                                                                                 through
                                                                            December 31, 2005
                                                 2005            2004
<S>                                            <C>              <C>         <C>


CASH FLOWS FROM FINANCING ACTIVITIES

Net Income (Loss)                            $ (10,000)     $ (10,000)   $          (38,500)


Adjustments to reconcile net loss to cash
used in operating activities:
Increase in accounts payable - Director         10,000         10,000                37,500
                                              ---------     ----------         --------------

Net Cash Used By Operating Activities                0              0               (1,000)
                                              ---------     ----------         --------------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock               0              0                 1,000

Net cash provided from financing activities          0              0                 1,000
                                              ---------     ----------         --------------
Net increase (Decrease) in cash                      0              0                     0

Cash at beginning of year                            0              0                     0
                                              ---------     ----------         --------------
Cash at end of year                         $        0     $        0   $                 0
                                              =========     ==========         ==============
</TABLE>

              The accompanying notes are an integral part of these
                             financial statements.


                                       7
<PAGE>

                          NOTES TO FINANCIAL STATEMENTS

1.       DESCRIPTION OF BUSINESS

Med-X Systems, Inc. was incorporated in the State of Texas on December 21, 1987
to engage in the business of the management and processing of insurance claims
for the medical profession. UNICORP acquired 100% of the outstanding capital
stock of Med-X on July 31, 1988. The Company ceased active business operations,
liquidated its operating assets in 1989, and had no material business operations
since that time. The Company is now considered a development stage enterprise
because it has not yet commenced new commercial operations and because its
current efforts are focused almost entirely on corporate structure and capital
raising activities.

On August 17, 2001 to facilitate a spin-off of Med-X Systems, Inc. to its
shareholders, Unicorp, Inc. the parent of Med-X Systems, Inc. caused Med-X
Systems, Inc. to file a registration statement with United States Securities &
Exchange Commission. This registration became effective on October 16, 2001.
However, the spin-off of Med-X Systems, Inc. although approved in 2001, was not
completed until the close of business on September 30, 2004. Under the terms of
the spin-off, each shareholder of Unicorp, Inc. received, or is entitled to
receive, one share of Med-X Systems, Inc. common stock for each share of common
stock held of Unicorp, Inc.

The date of inception of the development stage of the Company for purposes of
financial reporting is considered to be January 1, 1999, because on or about
that date management began planning future activities for the dormant Company.
Accordingly, in accordance with Statement of Financial Accounting Standards #7,
Accounting and Reporting by Development Stage Enterprises, the accompanying
financial statements include cumulative amounts from January 1, 1999, the
inception of the development stage.

2.       SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

GOING CONCERN

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenue sufficient to cover
its operating costs and to allow it to continue as a going concern. It is the
intent of the Company to seek a merger with an existing, operating company.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents include all cash balances and any highly liquid
short-term investments with an original maturity of three months or less.

INCOME TAXES

The Company uses the asset and liability method of accounting for income taxes.
Under the asset and liability method, deferred tax assets and liabilities are
recognized for the estimated future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases. This method also requires the
recognition of future tax benefits such as net operating loss carryforwards, to
the extent that realization of such benefits is more likely than not. Deferred
tax assets and liabilities are measured using enacted tax rates expected to
apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that
includes the enactment date.


                                       8
<PAGE>


NET LOSS PER COMMON SHARE

Basic and dilutive net loss per common share for the years ended December 31,
2005 and 2004 have been computed by dividing net loss by the weighted average
number of shares of common stock outstanding during these periods.

ESTIMATES

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts or revenues an expenses during the reporting period. Actual
results could differ from those estimates.

FAIR VALUE OF FINANCIAL INSTRUMENTS

The company includes fair value information in the notes to the financial
statements when the fair value of its financial instruments is different from
the book value. When the book value approximates fair value, no additional
disclosure is made.

COMPREHENSIVE INCOME

The Company has adopted Statement of Financial Accounting Standard ("SFAS") No.
130, "Reporting Comprehensive Income." Comprehensive income includes such items
as unrealized gains or losses on certain investment securities and certain
foreign currency translation adjustments. The Company's financial statements
include none of the additional elements that affect comprehensive income.
Accordingly, comprehensive income and net income are identical.

3.       ACCOUNTS PAYABLE - DIRECTOR

The accounts payable balance of $37,500 and $27,500 at December 31, 2005 and
2004 respectively, is an advance by a shareholder/director, convertible into
Company's common stock at a rate of 10 shares for every $1 advanced. The payable
is convertible into common stock at the option of the holder.

4.       INCOME TAXES

No provision for income taxes has been recorded due to operating losses at
December 31, 2005. The Company has a net operating loss carry forward of
approximately $38,500 of which the majority will expire on 2022. The utilization
of the net operating loss carry forward may be limited by Internal Revenue Code
382. The Company has a future tax benefit of $13,475 computed at the statutory
rate, offset a valuation allowance of $13,475.

5.       STOCKHOLDERS' EQUITY

On June 19, 2001, the Company amended it articles of incorporation to increase
its authorized shares from 10,000,000 to 250,000,000 and create two classes of
stock, as follows:

-        50,000,000 shares of no par value serial preferred stock
         for which the Company's board of directors may set the
         relative rights, preferences qualifications, limitations
         and restrictions.
-        200,000,000 of no par value common stock


                                       9
<PAGE>


ITEM 8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
         FINANCIAL DISCLOSURE

There have been no changes in the company's accounting and financial disclosure
methods nor has there been any disagreements with the accountants on accounting
and financial disclosure.

ITEM 8A.          CONTROLS AND PROCEDURES

It is management's responsibility to establish and maintain adequate internal
control over financial reporting.

As of the end of the period covered by this report, we have evaluated the
effectiveness of the design and operation of our disclosure controls and
procedures under the supervision of and with the participation of our Chief
Executive Officer ("CEO") who is also our Chief Financial Officer ("CFO"). Based
on this evaluation, our management, including our CEO / CFO, concluded that our
disclosure controls and procedure were effective, that there have been no
significant changes in our internal controls or in other factors that could
significantly affect internal controls subsequent to the evaluation.

During the period covered by this report there have been no changes in internal
control over financial reporting.

ITEM 8B.          OTHER INFORMATION

None

                                    PART III

ITEM 9. DIRECTORS,  EXECUTIVE OFFICERS, PROMOTERS, CONTROL PERSONS AND CORPORATE
        GOVERANCE COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

The following table sets forth the names and ages of the present executive
officers and directors of the Company and the positions held by each.

Name               Age        Title

Hank Vanderkam     62     Chief Executive Officer, Chief Financial
                          Officer, and Director

The directors has been elected to serve until the next annual meeting of the
shareholders or until his successor has been duly elected and qualified.

Hank Vanderkam was elected Chief Executive Officer, Chief Financial Officer, and
Director on April 1, 2002. Mr. Vanderkam is a certified public accountant and
attorney and practices law in Houston, Texas.


ITEM 10. EXECUTIVE COMPENSATION

No executive or director received compensation during the years ended December
31, 2005 and 2004.

ITEM 11.          SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

There are no compensation plans, or individual compensation arrangements of the
small business issuer as of December 31, 2005 and 2004.

As of December 31, 2005 and 2004, Equitable Assets, Inc. owned 474,589 of the
596,469 shares, of common stock outstanding.

                                       10
<PAGE>

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Funds for keeping the company current in its filings are being furnished by the
Company's chief executive officer.

No other relationships existed and no other related transactions occurred that
require disclosure under Reg. ss.228.404.

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K

None

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

                                   Audit & Related
                                   Services
               2004                $4,500
               2005                $4,500



                                   SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                               MED-X SYSTEMS, INC.


                               By:  /s/Hank Vanderkam
                                  --------------------------------
                                 Hank Vanderkam
                                 Executive Officer & Chief Financial Offier
Dated: January 4, 2007

In accordance with the Exchange Act, this report has been signed below by the
following persons on behalf of the Registrant and in the capacities and on the
dates indicated.

Name                       Title                              Date
/s/Hank Vanderkam
Hank Vanderkam             Chief Executive Officer            January 4, 2007
                           Chief Financial Officer &
                           Director


                                       11
<PAGE>

                                 CERTIFICATIONS

I, Hank Vanderkam, certify that:

1. I have reviewed this annual report on Form 10-KSB of Med-X Systems, Inc.

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and I have:

         a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, is made known to me by others
within those entities, particularly during the period in which this annual
report is being prepared;

         b) evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of this
annual report (the "Evaluation Date"); and

         c) presented in this annual report my conclusions about the
effectiveness of the disclosure controls and procedures based on my evaluation
as of the Evaluation Date;

5. I have disclosed, based on my most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent function):

         a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

         b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal
controls; and

6. I have indicated in this annual report whether or not there were significant
changes in internal controls or in other factors that could significantly affect
internal controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant deficiencies and
material weaknesses.

Dated: January 4, 2007

By: /s/ Hank Vanderkam
Hank Vanderkam
Chief Executive Officer and Chief Financial Officer




                                       12
<PAGE>


CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO
18  U.S.C.   SECTION  1350,   AS  ADOPTED   PURSUANT  TO  SECTION  906  OF  TEHE
SARBANES-OXLEY ACT OF 2002

I, Hank Vanderkam, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual
Report of Med-X Systems, Inc. on Form 10-KSB for the annual period ended
December 31, 2005 fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934 and that information contained in such
Form 10-KSB fairly presents in all material respects the financial condition and
results of operations of Med-X Systems, Inc

By: /s/ Hank Vanderkam
----------------------------
Name: Hank Vanderkam
Title: Chief Executive Officer
& Chief Financial Officer

January 4, 2007
                                       13